Böblingen / Łódź (Poland), May 2026 – Five years ago, Wörwag Pharma took an important strategic step by integrating its own manufacturing operations. Today, Wörwag Pharma Operations (WPO) is a reliable part of the Group and makes a key contribution to the safe and high‑quality supply of patients worldwide.
5 Years of Wörwag Pharma Operations: A Stable Pillar for Quality and Supply
What began in 2021 as a focused transformation has developed into a strong operational base. The production site in Poland has become an important manufacturing partner within the Group, supporting Wörwag Pharma’s international markets with modern processes, high quality standards and close collaboration.
Over the past five years, targeted investments have been made in people, technologies and structures. This continuous development has strengthened production and quality capabilities and has further enhanced the site’s long‑term reliability and performance.
Since its integration, Wörwag Pharma Operations has also consistently expanded its manufacturing capacities and further consolidated its role within the Group. Today, the site reliably supplies a wide range of international markets and supports the Group’s growing requirements with stable processes and high quality standards.
“This anniversary is above all an opportunity to say thank you,” the company states. “The success of Wörwag Pharma Operations is built on the daily dedication, professionalism and strong quality mindset of the teams on site.”
About Wörwag Pharma Operations
Wörwag Pharma Operations (WPO) is one of the company’s own production sites within the Wörwag Pharma Group. Located in the Łódź Special Economic Zone in Poland, the site manufactures solid oral dosage forms in accordance with high pharmaceutical and regulatory standards for international markets. As part of the Group’s production network, Wörwag Pharma Operations makes an important contribution to quality, safety and the reliable supply of patients worldwide.